Article Information
History
- May 26, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- N Demnitz1,2,
- M Anatürk1,
- CL Allan3,4,
- N Filippini5,
- L Griffanti1,
- CE Mackay1,5,
- A Mahmood6,
- CE Sexton5,
- S Suri5,
- AG Topiwala1,
- E Zsoldos1,5,
- M Kivimäki7,
- A Singh-Manoux7,8 and
- KP Ebmeier1,*
- 1Department of Psychiatry, University of Oxford, Oxford, UK
- 2Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland
- 3Institute of Translational and Clinical Research, Newcastle University, UK
- 4Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust, UK
- 5Oxford Centre for Human Brain Activity, Wellcome Centre for Integrative Neuroimaging, Department of Psychiatry, University of Oxford, UK
- 6Department of Population Health, London School of Hygiene and Tropical Medicine, London, UK
- 7Department of Epidemiology and Public Health, University College London, London, UK
- 8Université de Paris, INSERM U1153, Paris, France
- ↵*Corresponding Author: K P Ebmeier, Department of Psychiatry University of Oxford, Warneford Hospital, Oxford OX3 7JX, UK. Email: naiara.demnitz{at}gbhi.org
Posted May 26, 2020.
Association of trajectories of depressive symptoms with vascular risk, cognitive function and adverse brain outcomes: The Whitehall II MRI sub-study
